{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:27:20Z","timestamp":1783330040736,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI169296"],"award-info":[{"award-number":["R01 AI169296"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.xphs.2025.103919","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T15:09:30Z","timestamp":1753283370000},"page":"103919","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Single-cell transcriptional analysis of murine mesenteric lymph nodes following oral lyso-phosphatidylserine nanoparticle administration reveals cellular heterogeneity in tolerance features"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0506-9125","authenticated-orcid":false,"given":"Vincent","family":"Chak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6557-2817","authenticated-orcid":false,"given":"Edwin J.","family":"Ovalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7433-0086","authenticated-orcid":false,"given":"Jonathan","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7936-8614","authenticated-orcid":false,"given":"Elizabeth A.","family":"Wohlfert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8944-6612","authenticated-orcid":false,"given":"Jason G.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0569-2865","authenticated-orcid":false,"given":"Sathy","family":"Balu-Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.xphs.2025.103919_bib0001","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1398-9995.2007.01501.x","article-title":"Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction","volume":"62","author":"Staden","year":"2007","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.xphs.2025.103919_bib0002","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1111\/all.14758","article-title":"Overview of oral tolerance induction for prevention of food allergy-where are we now?","volume":"76","author":"Krawiec","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.xphs.2025.103919_bib0003","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.xphs.2025.103919_bib0004","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1812856","article-title":"AR101 Oral immunotherapy for peanut allergy","volume":"379","author":"Investigators","year":"2018","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.xphs.2025.103919_bib0005","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1001\/jama.2017.17070","article-title":"Effect of oral insulin on prevention of diabetes in relatives of patients with type 1 diabetes: A randomized clinical trial","volume":"318","year":"2017","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.xphs.2025.103919_bib0006","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/diacare.28.5.1068","article-title":"Effects of oral insulin in relatives of patients with type 1 diabetes: the Diabetes Prevention Trial\u2013Type 1","volume":"28","author":"Skyler","year":"2005","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0007","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/1529-0131(199802)41:2<290::AID-ART13>3.0.CO;2-R","article-title":"Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial","volume":"41","author":"Barnett","year":"1998","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0008","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/art.1780390106","article-title":"Oral type II collagen treatment in early rheumatoid arthritis. A double-blind, placebo-controlled, randomized trial","volume":"39","author":"Sieper","year":"1996","journal-title":"Arthritis Rheum"},{"issue":"5099","key":"10.1016\/j.xphs.2025.103919_bib0009","first-page":"1321","article-title":"Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis","volume":"259","author":"Weiner","year":"1993","journal-title":"Science (1979)"},{"issue":"8","key":"10.1016\/j.xphs.2025.103919_bib0010","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/j.xphs.2018.03.027","article-title":"Phosphatidylserine is not just a cleanup crew but also a well-meaning teacher","volume":"107","author":"Glassman","year":"2018","journal-title":"J Pharm Sci"},{"issue":"4","key":"10.1016\/j.xphs.2025.103919_bib0011","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4049\/jimmunol.1601520","article-title":"Efferocytosis signaling in the regulation of macrophage inflammatory responses","volume":"198","author":"Elliott","year":"2017","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103919_bib0012","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1002\/jps.21102","article-title":"Phosphatidylserine containing liposomes reduce immunogenicity of recombinant human factor VIII (rFVIII) in a murine model of hemophilia A","volume":"97","author":"Ramani","year":"2008","journal-title":"J Pharm Sci"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.clim.2010.10.006","article-title":"Phosphatidylserine reduces immune response against human recombinant Factor VIII in Hemophilia A mice by regulation of dendritic cell function","volume":"138","author":"Gaitonde","year":"2011","journal-title":"Clin Immunol"},{"issue":"24","key":"10.1016\/j.xphs.2025.103919_bib0014","doi-asserted-by":"crossref","first-page":"17051","DOI":"10.1074\/jbc.C112.396325","article-title":"Exposure to factor VIII protein in the presence of phosphatidylserine induces hypo-responsiveness toward factor VIII challenge in hemophilia A mice","volume":"288","author":"Gaitonde","year":"2013","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.xphs.2025.103919_bib0015","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.xphs.2016.06.018","article-title":"Phosphatidylserine converts immunogenic recombinant Human acid alpha-glucosidase to a tolerogenic form in a mouse model of Pompe disease","volume":"105","author":"Schneider","year":"2016","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97333-0","article-title":"Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins","volume":"11","author":"Nguyen","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0017","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijpharm.2018.07.018","article-title":"Subcutaneous administration of Lyso-phosphatidylserine nanoparticles induces immunological tolerance towards Factor VIII in a Hemophilia A mouse model","volume":"548","author":"Glassman","year":"2018","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1016\/j.xphs.2025.103919_bib0018","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/ac60119a033","article-title":"Microdetermination of phosphorus","volume":"28","author":"Chen","year":"1956","journal-title":"Analyt Chem,"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0019","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","article-title":"Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression","volume":"20","author":"Hafemeister","year":"2019","journal-title":"Genome Biol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","article-title":"Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage","volume":"20","author":"Aran","year":"2019","journal-title":"Nat Immunol"},{"issue":"D1","key":"10.1016\/j.xphs.2025.103919_bib0021","doi-asserted-by":"crossref","first-page":"D891","DOI":"10.1093\/nar\/gkad1049","article-title":"Ensembl 2024","volume":"52","author":"Harrison","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.xphs.2025.103919_bib0022","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innovation (Camb)"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0023","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.xphs.2025.103919_bib0024","article-title":"CellChat for systematic analysis of cell-cell communication from single-cell transcriptomics","author":"Jin","year":"2024","journal-title":"Nat Protoc"},{"issue":"4","key":"10.1016\/j.xphs.2025.103919_bib0025","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1681\/ASN.V44976","article-title":"CD45 and the immune response","volume":"4","author":"Donovan","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.xphs.2025.103919_bib0026","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.immunol.21.120601.140946","article-title":"CD45: a critical regulator of signaling thresholds in immune cells","volume":"21","author":"Hermiston","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"48","key":"10.1016\/j.xphs.2025.103919_bib0027","doi-asserted-by":"crossref","first-page":"30656","DOI":"10.1074\/jbc.271.48.30656","article-title":"Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the molecule","volume":"271","author":"Qian","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.xphs.2025.103919_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2017.07.004","article-title":"History and mechanisms of oral tolerance","volume":"30","author":"Rezende","year":"2017","journal-title":"Semin Immunol"},{"issue":"7","key":"10.1016\/j.xphs.2025.103919_bib0029","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.xphs.2025.103919_bib0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.imlet.2022.03.007","article-title":"Oral tolerance: an updated review","volume":"245","author":"Rezende","year":"2022","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0031","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jmcb\/mjr033","article-title":"TGF-\u03b2: the sword, the wand, and the shield of FOXP3+ regulatory T cells","volume":"4","author":"Tran","year":"2012","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/j.xphs.2025.103919_bib0032","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-230X-12-97","article-title":"Deletion of Foxp3+ regulatory T cells in genetically targeted mice supports development of intestinal inflammation","volume":"12","author":"Boehm","year":"2012","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.xphs.2025.103919_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104660","article-title":"Phosphatidylserine-mediated oral tolerance","volume":"384","author":"Nguyen","year":"2023","journal-title":"Cell Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0034","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0171-2985(99)80075-8","article-title":"Oral tolerance by a high dose OVA in BALB\/c mice is more pronounced and persistent in Th2-mediated immune responses than in Th1 responses","volume":"200","author":"Kang","year":"1999","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.xphs.2025.103919_bib0035","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.4049\/jimmunol.152.9.4663","article-title":"Oral tolerance in humans. T cell but not B cell tolerance after antigen feeding","volume":"152","author":"Husby","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.xphs.2025.103919_bib0036","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cellimm.2015.10.001","article-title":"In vivo induction of regulatory T cells for immune tolerance in hemophilia","volume":"301","author":"Wang","year":"2016","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.xphs.2025.103919_bib0037","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3748\/wjg.v23.i3.455","article-title":"Role of LAP(+)CD4(+) T cells in the tumor microenvironment of colorectal cancer","volume":"23","author":"Zhong","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"12","key":"10.1016\/j.xphs.2025.103919_bib0038","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.4049\/jimmunol.1101398","article-title":"Inducible CD4+LAP+Foxp3- regulatory T cells suppress allergic inflammation","volume":"187","author":"Duan","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.xphs.2025.103919_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109767","article-title":"Latency-associated peptide (LAP)(+)CD4(+) regulatory T cells prevent atherosclerosis by modulating macrophage polarization","volume":"255","author":"Yu","year":"2023","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0040","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-beta signaling in health, disease, and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"6488","key":"10.1016\/j.xphs.2025.103919_bib0041","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/370341a0","article-title":"Mechanism of activation of the TGF-beta receptor","volume":"370","author":"Wrana","year":"1994","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.xphs.2025.103919_bib0042","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1084\/jem.20012076","article-title":"Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation","volume":"195","author":"Gorelik","year":"2002","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.xphs.2025.103919_bib0043","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.4049\/jimmunol.165.9.4773","article-title":"Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression","volume":"165","author":"Gorelik","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0044","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.it.2012.11.002","article-title":"Differentiation and function of Foxp3(+) effector regulatory T cells","volume":"34","author":"Cretney","year":"2013","journal-title":"Trends Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103919_bib0045","first-page":"10","article-title":"Autocrine TGF-beta1 maintains the stability of Foxp3(+) regulatory T cells via IL-12Rbeta2 downregulation","author":"Choi","year":"2020","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.xphs.2025.103919_bib0046","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022236","article-title":"Regulation of the immune response by TGF-beta: from conception to autoimmunity and infection","volume":"9","author":"Sanjabi","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"9","key":"10.1016\/j.xphs.2025.103919_bib0047","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s41423-023-01036-7","article-title":"Intricacies of TGF-beta signaling in Treg and Th17 cell biology","volume":"20","author":"Wang","year":"2023","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"10.1016\/j.xphs.2025.103919_bib0048","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/eji.201344062","article-title":"TGF-beta-producing regulatory B cells induce regulatory T cells and promote transplantation tolerance","volume":"44","author":"Lee","year":"2014","journal-title":"Eur J Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2025.103919_bib0049","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/all.15973","article-title":"Early expansion of allergen-responsive LAP(+) B regulatory cells in allergic rhinitis but not in allergic asthma subjects during allergen immunotherapy","volume":"79","author":"Voskamp","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.xphs.2025.103919_bib0050","first-page":"175","article-title":"Anti-immunoglobulin treatment of murine B-cell lymphomas induces active transforming growth factor beta but pRB hypophosphorylation is transforming growth factor beta independent","volume":"3","author":"Warner","year":"1992","journal-title":"Cell Growth Differ"},{"issue":"3","key":"10.1016\/j.xphs.2025.103919_bib0051","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/85303","article-title":"Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta","volume":"2","author":"Kee","year":"2001","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.xphs.2025.103919_bib0052","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.4049\/jimmunol.159.9.4155","article-title":"Effect of TGF-beta1 on cell cycle regulatory proteins in LPS-stimulated normal mouse B lymphocytes","volume":"159","author":"Bouchard","year":"1997","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0053","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2567.2006.02346.x","article-title":"NKT cells play critical roles in the induction of oral tolerance by inducing regulatory T cells producing IL-10 and transforming growth factor beta, and by clonally deleting antigen-specific T cells","volume":"118","author":"Kim","year":"2006","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.xphs.2025.103919_bib0054","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.4049\/jimmunol.173.2.1043","article-title":"Oral tolerance to nickel requires CD4+ invariant NKT cells for the infectious spread of tolerance and the induction of specific regulatory T cells","volume":"173","author":"Roelofs-Haarhuis","year":"2004","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103919_bib0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/immu.200390021","article-title":"NKT cells are dispensable in the induction of oral tolerance but are indispensable in the abrogation of oral tolerance by prostaglandin E","volume":"33","author":"Ishimitsu","year":"2003","journal-title":"Eur J Immunol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925003715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:31:35Z","timestamp":1762209095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925003715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0022354925003715"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103919","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-cell transcriptional analysis of murine mesenteric lymph nodes following oral lyso-phosphatidylserine nanoparticle administration reveals cellular heterogeneity in tolerance features","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103919","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103919"}}